Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets
British Journal of Pharmacology2017Vol. 175(8), pp. 1173–1189
Citations Over TimeTop 10% of 2017 papers
Abstract
This article is part of a themed section on Spotlight on Small Molecules in Cardiovascular Diseases. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v175.8/issuetoc.
Related Papers
- → Chronic Kidney Disease Influences Multiple Systems: Describing the Relationship between Oxidative Stress, Inflammation, Kidney Damage, and Concomitant Disease(2015)198 cited
- → PM2.5 exposure induces vascular dysfunction via NO generated by iNOS in lung of ApoE-/- mouse(2019)42 cited
- → Homocysteine Induces DNA Synthesis and Proliferation of Vascular Smooth Muscle Cells by a Hydrogen Peroxide-Independent Mechanism(1999)25 cited
- → The role of exercise on oxidative stress and inflammation in the aging brain(2012)1 cited
- → Homocysteine as a Risk Factor for Peripheral Vascular Disease(2000)3 cited